หน้าแรก
ค้นหา
CNBC Jim Cramer on drugs?!
No description available
แสดงข้อมูลเพิ่มเติม 1
Jim Cramer Says It's 'Very Hard To Put A Price On' Lifesaving Drugs | CNBC
CNBC Jim Cramer on drugs?!
This year healthcare is the worst performing part of the market by far, says Jim Cramer
Jim Cramer: There will be push back on Biogen's Alzheimer's drug price
Biggest indicators for weight loss drugs are yet to come, says Jim Cramer
Amgen CEO talks trial results of cardiac drug Repatha
Eli Lilly may have developed the greatest drug of all time, says Jim Cramer
Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 billion
'Things are never so rosey that you can't have a drug stock in your portfolio', says Jim Cramer
Jim Cramer: Remdesivir is just what the doctor ordered
Cramer’s Mad Dash on Vertex: Their non-opioid pain innovation could be 'the holy grail of medical'
Jim Cramer breaks down drug stocks amid concerns over Zantac litigation
Jim Cramer: Drug Stocks Are Underperforming ‘Like Nothing I’ve Ever Seen’
GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC
Jim Cramer: Drug companies would be a good place to go if the market falls apart
Eli Lilly's experimental obesity drug could be 'revolutionary,' says Jim Cramer
Recursion Pharmaceuticals CEO Chris Gibson goes one-on-one with Jim Cramer
Mallinckrodt To Buy Questcor | Mad Money | CNBC
Jim Cramer dissects how GLP-1 drugs are disrupting the entire healthcare industry
Jim Cramer says there's a buying opportunity in this pharmaceutical company
GW Pharmaceuticals CEO: Pot Play | Mad Money | CNBC
Jim Cramer Now Sees Value In Drug Stock Valeant After Its CEO ‘Delivered’
Jim Cramer on Eli Lilly's Covid-19 phase 2 trial results for antibody drug
Cramer's Mad Dash: Abbott Labs
Cramer: This biotech stock could be worth over $100 billion on an FDA approval
